Extracellular Matrix Scaffolds for Folded Micro-Tissue Delivery

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for cell injection therapy involve single cell suspensions that cause structural changes and rapid cell death due to physical stress and lack of tissue attachment, making it difficult for cells to effectively repair damaged organs and tissues.

Innovation Solution

The formation of small intact 2D micro-tissues using an extracellular matrix scaffold that maintains cell structure and phenotype, providing protection and attachment sites during delivery, achieved through a method involving a thermoresponsive substrate and solvent-based folding process.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If cells are delivered as single cell suspension, then injection is simple, but cells die quickly due to physical stress and lack of attachment

Engineering Contradiction:
Improveinjection simplicityVSAvoidcell survival rate
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent uses a flexible hydrogel shell to encapsulate cells, forming a protective microenvironment that shields cells from physical stress during injection while maintaining cell viability and promoting attachment

Inventive Principle:
Principle #30Flexible shells and thin films

Solution Approach 2:

The hydrogel acts as an intermediary between the injection process and cells, absorbing mechanical stress and providing attachment sites, thereby mediating the interaction between delivery method and cell survival

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If enzymatic release is used to create cell suspension, then cells can be injected, but cellular structure and phenotype change

Engineering Contradiction:
Improvecell delivery capabilityVSAvoidcellular structure integrity
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent extracts cells from tissue without using enzymes that damage cellular structure, instead employing mechanical dissociation methods that preserve cell integrity and phenotype while enabling delivery

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The hydrogel scaffold is prepared in advance with attachment sites before cell encapsulation, allowing cells to maintain their structure and phenotype during the encapsulation process without requiring enzymatic treatment

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If cells are injected without attachment sites, then injection is straightforward, but cells cannot attach to desired tissue for repair

Engineering Contradiction:
Improveinjection easeVSAvoidtissue attachment capability
Core Design Contradiction:
Ease of operationVSAdaptability or versatility

Solution Approach 1:

The hydrogel scaffold serves multiple functions simultaneously: it provides mechanical protection during injection, offers attachment sites for tissue integration, and maintains cell viability, thereby combining ease of delivery with tissue repair capability

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method allows cells to maintain their structure and phenotype during delivery, enhancing their ability to repair tissues by protecting them from physical stress and ensuring proper attachment, thereby improving therapeutic efficacy.

Implementation Method 1

removing the thermoresponsive substrate by lowering the temperature

Methodology Applied
Scientific EffectThermal contraction: Thermal Contraction

Implementation Method 2

removing the tissue scaffold stamp from the cell patch to form a micro-tissue structure by dissolving the tissue scaffold stamp in a solvent

Methodology Applied
Scientific EffectDissolution: Solvation

Data Source

PatentUS12441981B2Extracellular matrix scaffolds
Publication Date: 2025.10.14 CARNEGIE MELLON UNIV
  • US12441981B2 patent drawing
  • US12441981B2 patent drawing
  • US12441981B2 patent drawing

AI summary

A method for micro-tissue encapsulation of cells includes coating a tissue scaffold stamp with an extracellular matrix compound; depositing the tissue scaffold stamp onto a thermoresponsive substrate; seeding the tissue scaffold stamp with a cell culture; incubating the cell culture on the tissue scaffold stamp at a temperature that is specified, wherein the cell culture forms a cell patch that is attached to the extracellular matrix compound; removing the thermoresponsive substrate by lowering the temperature; removing the tissue scaffold stamp from the cell patch to form a micro-tissue structure by dissolving the tissue scaffold stamp in a solvent; folding the micro-tissue structure by suspending the micro-tissue in the solvent to enable the cell patch to fold the micro-tissue structure; collecting the folded micro-tissue structure from the solvent; and administering the folded micro-tissue structure to an organism.